|
Monoclonal and Polyclonal Antibodies
|
|
|
MAb to Akt (19G7), Mouse IgG1
|
ALX-803-303
|
|
MAb to Akt (5C10), Mouse IgG1
|
ALX-804-553
|
|
MAb to Akt (5C10), Mouse IgG1
|
NT-0119
|
|
MAb to AKT (8F4), Mouse IgG1
|
BML-SA312
|
|
MAb to AKT (dephosphorylated) (11A11), Mouse IgG1
|
BML-SA313
|
|
MAb to Akt (dephosphorylated) (11A11), Mouse IgG1
|
ALX-804-400
|
|
MAb to Akt (dephosphorylated) (Ser473) (11A11), Mouse
IgG1
|
NT-0049
|
|
MAb to Akt1 (5G12), Mouse IgG1
|
ALX-804-633
|
|
MAb to Akt1 (5G12), Mouse IgG1
|
NT-0144
|
|
MAb to Akt2 (human) (8B7), Mouse IgG2a
|
ALX-804-634
|
|
MAb to Akt2 (human) (8B7), Mouse IgG2a
|
NT-0179
|
|
MAb to Akt3 (human) (66C1247.1), Mouse IgG1
|
ALX-804-379
|
|
MAb to PDK Substrate (phosphorylated) (2D2), Mouse
IgG1
|
ALX-804-397
|
|
MAb to PDK Substrate (phosphorylated) (2D2), Mouse
IgG1
|
NT-0056
|
|
MAb to PDK Substrate (phosphorylated) (4E1), Mouse
IgG1
|
ALX-804-398
|
|
MAb to PDK Substrate (phosphorylated) (4E1), Mouse
IgG1
|
NT-0057
|
|
MAb to Phosphoinositide 3-kinase p110γ (H1), Mouse IgG2a |
ALX-804-230 |
|
MAb to PI 3-Kinase (p85α Subunit) (8-2D-4D), Mouse IgG1 |
BML-SA269 |
|
MAb to PTEN (11G8.1), Mouse IgG |
ALX-804-451 |
|
MAb to PTEN (6H2.1), Mouse IgG |
ALX-804-254 |
|
MAb to Raptor (10E10), Mouse IgG1 |
NT-0255 |
|
MAb to Rictor (1G11), Mouse IgG1 |
NT-0250 |
|
MAb to αhPI(3)Kγ (641) |
JBS-ABD-027 |
|
MAb to αhPI(3)Kγ (641) |
JBS-ABD-027P |
|
MAb to αhPI(3)Kγ (H1) |
JBS-ABD-026L |
|
MAb to αhPI(3)Kγ (H1) |
JBS-ABD-026S |
|
MAb to Akt (phosphorylated) (pSer473) (11E6), Mouse IgG1 |
ALX-804-401 |
|
MAb to Akt (phosphorylated) (pSer473) (11E6), Mouse IgG1 |
NT-0108 |
|
MAb to PIP2 (human) (2C11), IgM |
ABR-MA3-500 |
|
MAb to SHIP-1 (human) (SHIP-01) (Purified), Mouse IgG2a |
EXB-11-524 |
|
MAb to SHIP-1 (human) (SHIP-02) (Purified), Mouse IgG2a |
EXB-11-525 |
|
Monoclonal Antibody to Omentin 1 (human) (Saly-1), Mouse IgG2b |
ALX-804-850 |
|
Monoclonal Antibody to Omentin 1 (human) (Saly-2), Mouse IgG2a |
ALX-804-852 |
|
PAb to Akt (activated) (pSer473) |
BV-3257 |
|
PAb to Akt (phosphorylated) (pSer473), From rabbit. |
BML-SA450 |
|
PAb to Akt (phosphorylated) (pThr308), From rabbit. |
BML-SA290 |
|
PAb to Akt, From rabbit. ; anti-PKB PAb; anti-Protein Kinase B PAb |
ALX-210-226 |
|
PAb to Akt/PKB |
BV-3247 |
|
PAb to Akt1 (NT), From rabbit. |
PSC-3519 |
|
PAb to FKBP12 |
BV-3635 |
|
PAb to FKBP12, From rabbit. |
ABR-PA1-026A |
|
PAb to G Protein β Subunit-like |
PSC-3495 |
|
PAb to Inositol 1,4,5-trisphosphate Receptor (Type-I), From rabbit. |
ALX-210-115 |
|
PAb to Inositol 1,4,5-trisphosphate Receptor (Type-I), From rabbit. |
ALX-210-169 |
|
PAb to Inositol 1,4,5-Trisphosphate Receptor (Type-I), From rabbit. |
ABR-PA1-901 |
|
PAb to Inositol 1,4,5-Trisphosphate Receptor (Type-I), From rabbit. |
ABR-PA3-901A |
|
PAb to Inositol 1,4,5-Trisphosphate Receptor (Type-II) (rat), From
rabbit. |
ABR-PA1-904 |
|
PAb to Inositol 1,4,5-trisphosphate Receptor (Type-II), From rabbit. |
ALX-210-224 |
|
PAb to Inositol Hexakisphosphate [IP6] Kinase (rat), From rabbit. |
ABR-PA1-906 |
|
PAb to mTOR |
ABR-PA1-518 |
|
PAb to mTOR (human FRB Domain), From rabbit. ; anti-mTOR (human
FKBP12-rapamycin-binding Domain) PAb |
ALX-215-065 |
|
PAb to mTOR (NT), From rabbit. |
PSC-3485 |
|
PAb to mTOR , From rabbit. ; anti-Mammalian Target of Rapamycin PAb;
anti-FRAP1 PAb |
ALX-210-065 |
|
PAb to Omentin 1 (AT117), From rabbit. |
ALX-210-941 |
|
PAb to Omentin 1 (human), From rabbit. |
ALX-210-454 |
|
PAb to p70 S6 Kinase |
BV-3485 |
|
PAb to p70 S6 Kinase (activated) |
BV-3505 |
|
PAb to PDK1 |
BV-3449 |
|
PAb to PH Domain Leucine-rich Repeat Protein Phosphatase, From rabbit. |
CAY-10007191 |
|
PAb to PIKE (CT), From rabbit. |
PSC-3321 |
|
PAb to pp36 (human), From rabbit. |
ALX-210-770 |
|
PAb to PRAS40 (phosphorylated) (pThr246), From rabbit. |
BML-SA360 |
|
PAb to Protein Kinase B (mouse), From rabbit. |
ABR-PA1-540 |
|
PAb to PTEN |
BV-3479 |
|
PAb to PTEN (CT), From rabbit. |
PSC-3515 |
|
PAb to PTEN (NT), From rabbit. |
PSC-3517 |
|
PAb to PTEN Induced Putative Kinase 1 (PINK1) |
CAY-10006283 |
|
PAb to PTEN, From rabbit. |
CAY-10005059 |
|
PAb to Raptor (IN), From rabbit. |
PSC-3493 |
|
PAb to Raptor (mouse) (CT) |
PSC-3489 |
|
PAb to Raptor (NT) |
PSC-3491 |
|
PAb to Ribosomal Protein S6 Kinase (70kDa) (human) (phosphorylated)
(pThr389), From rabbit. |
ABR-PA1-526 |
|
PAb to Ribosomal Protein S6 Kinase 1 (human) (NT), From rabbit. |
PSC-3511 |
|
PAb to Ribosomal S6 Kinase 2 (rat), From rabbit. |
CAY-10009411 |
|
PAb to TSC1 (CT), From rabbit. |
PSC-3503 |
|
PAb to TSC1 (IN), From rabbit. |
PSC-3505 |
|
PAb to TSC2 (CT), From rabbit. |
PSC-3507 |
|
PAb to TSC2 (NT), From rabbit. |
PSC-3509 |
|
PAb to Akt1 (85-100) (human) (Purified), From rabbit. |
EXB-11-509 |
|
PAb to CARP, From rabbit. |
ABR-PA3-852 |
|
PAb to PTEN (human) (CT) (Purified), From rabbit. |
EXB-11-510 |
|
PAb to PTEN, From rabbit. |
ABR-PA1-808 |
|
PAb to WIPI-1 (AT130), From rabbit. |
ALX-210-955 |
|
PAb to WIPI-1 (human) (AT129), From rabbit. |
ALX-210-954 |
|
PAb to Akt (mouse), From rabbit. |
ALX-210-534 |
|
PAb to FKBP12, From rabbit. |
ALX-210-142 |
|
PAb to Inositol Hexakisphosphate Kinase (rat), From rabbit. |
ALX-210-289 |
|
PAb to Phosphatidylinositol-4-phosphate 5-kinase-Iγ, From rabbit. |
ALX-210-745 |
|
PAb to Phosphoinositide 3-Kinase p110δ (human), From rabbit. |
ALX-210-747 |
|
PAb to Ribosomal Protein S6 Kinase (70kDa) (human) (phosphorylated)
(pThr389), From rabbit. |
ALX-210-068 |
|
PAb to Tribbles Homolog 3, From rabbit. |
CVL-PAB0406 |
|
Polyclonal Antibody to mTOR |
BV-3786 |
|
Polyclonal Antibody to TRB-3 (human), From rabbit. |
ALX-210-462 |
|
Recombinant Proteins |
|
|
Akt (human) (recombinant) Western Ready Control |
CAY-10010079 |
|
Akt1 (active) |
BV-7701 |
|
Akt1 (human) (recombinant) |
BML-SE260 |
|
Akt1 (human) (recombinant) |
BML-SE416 |
|
Akt1/ PKBαHis (human) (recombinant) (active) |
JBS-PR-324 |
|
Akt1/ PKBαHis, inactive |
JBS-PR-325 |
|
Akt2 (active) |
BV-7702 |
|
Akt2 (human) (recombinant) |
BML-SE247 |
|
Akt2 (human) (recombinant) (activated) |
BML-SE248 |
|
Akt2/PKBβHis (human) (recombinant) (active) |
JBS-PR-333 |
|
Akt3 (active) |
BV-7703 |
|
Akt3 (human) (recombinant) |
BML-SE369 |
|
Akt3/ PKBγHis (human) (recombinant) (active) |
JBS-PR-334 |
|
Omentin 1 (human) (recombinant) |
ALX-522-108 |
|
Omentin 1 (human) (recombinant) (His) |
ALX-201-371 |
|
Omentin (rat) (recombinant) |
ALX-522-132 |
|
p70 S6 Kinase (human) (recombinant) |
BML-SE345 |
|
P70 S6K (active) |
BV-7725 |
|
pCAF Histone Acetyltransferase (human) (recombinant) (GST) |
CAY-10009115 |
|
PDK1 (active) |
BV-7706 |
|
Phosphoinositide 3-kinase p110α/p85 (bovine) (recombinant) |
ALX-201-119 |
|
Phosphoinositide 3-kinase p110γ (human) (recombinant) |
ALX-201-055 |
|
Phosphoinositide 3-kinase p85α (Regulatory Subunit) (bovine) (recombinant) |
JBS-PR-342 |
|
PI3 Kinase (human) (recombinant) |
BML-SE436 |
|
PI3 Kinase α (bovine) (recombinant) |
JBS-PR-341 |
|
PI3 Kinase α GST (bovine) (recombinant) |
JBS-PR-940 |
|
PI3 Kinase α R916P GST (bovine) (recombinant) |
JBS-PR-941 |
|
PI3 Kinase βHis (human) (recombinant) |
JBS-PR-344 |
|
PI3 Kinase γ D946A GST (human) (recombinant) |
JBS-PR-346 |
|
PI3 Kinase γ His (human) (recombinant) |
JBS-PR-343 |
|
PI3 Kinase δ GST (human) (recombinant) |
JBS-PR-345 |
|
PRAS40 (human) (recombinant) |
BML-SE308 |
|
PtdIns-(3,4,5)-P3 Binding Protein (E.coli) (recombinant) (GST) |
CAY-10009817 |
|
PtdIns-(4)-P1 Binding Protein (E. coli) (recombinant) (GST) |
CAY-10009241 |
|
PtdIns-(4,5)-P2 Binding Protein (E. coli) (recombinant) (GST) |
CAY-10009815 |
|
PTEN (human) |
BV-4838 |
|
PTEN (human) (recombinant) |
BML-SE402 |
|
PTEN (human) (recombinant) (GST) Western Ready Control |
CAY-10009747 |
|
PTEN (human) (recombinant) (His) |
CAY-10009746 |
|
RSK1 (human) (recombinant) |
BML-SE429 |
|
RSK2 (recombinant) (active) |
BV-7768 |
|
RSK3 (recombinant) (active) |
BV-7774 |
|
Ship2 (human) (recombinant) |
BML-SE539 |
|
Assay Kits & Sets |
|
|
KinaseSTAR Akt Activity Assay Kit |
BV-K435 |
|
Omentin 1 (human) Detection Set [For ELISA Application] |
APO-54N-026 |
|
Omentin 1 (human) ELISA Kit |
APO-54N-034 |
|
PI3K Lipid Kinase Substrate Mix 1 |
JBS-LI-011 |
|
PI3K Lipid Kinase Substrate Mix 2 |
JBS-LI-012 |
|
TOR Signalling Pathway Detection Set |
PSC-PSI-1805 |
|
Substances |
|
|
(-)-Epigallocatechin gallate |
ALX-270-263 |
|
(+)-Xestospongin A |
CAY-10006794 |
|
()-Naringenin |
ALX-385-010 |
|
1,2-Di-O-butyryl-D-myo-inositol 3,4,5,6-tetrakisphosphate octakis(propionoxymethyl)ester |
ALX-307-063 |
|
1-D-3-Deoxy-phosphatidylinositol |
ALX-307-002 |
|
1L-6-Hydroxymethyl-chiro-inositol-2-[(R)-2-O-methyl-3-O-octadecylcarbonate] |
ALX-270-292 |
|
2,3-Di-O-butyryl-D-myo-inositol 1,4,5,6-tetrakisphosphate octakis(propionoxymethyl)ester |
ALX-307-060 |
|
2,5,6-Tri-O-butyryl-D-myo-inositol 1,3,4-trisphosphate hexakis(acetoxymethyl)ester
; Bt3Ins(1,3,4)P3/AM |
ALX-307-045 |
|
3-Deoxy-3-bromo-D-myo-inositol 1,4,5-trisphosphate . hexasodium salt |
ALX-307-018 |
|
3-Deoxy-3-fluoro-D-myo-inositol 1,4,5-trisphosphate . hexasodium salt |
ALX-307-021 |
|
6BIO |
ALX-430-156 |
|
Akt (pSer473) Control Peptide Pair |
BML-SP288 |
|
Akt (pThr308) Control Peptide Pair |
BML-SP290 |
|
Akt Inhibitor |
BV-1701 |
|
Akt Substrate |
BML-P129 |
|
AKT/PKB substrate peptide |
JBS-PE-200 |
|
Araguspongin B |
CAY-10006797 |
AS-252424
PI(3)K p110γ Isoform
Selective Inhibitor. Potent and selective phosphoinositide 3-kinase (PI(3)K) p110γ inhibitor shown to be
selective for class IB PI(3)K-mediated cellular effects. LIT: Sequential activation of class IB and class IA PI3K is important
for the primed respiratory burst of human but not murine neutrophils: A.M. Condliffe, et al.; Blood 106, 1432
(2005) - Furan-2-ylmethylene thiazolidinediones as novel, potent, and selective inhibitors of phosphoinositide 3-kinase
gamma: J. Med. Chem. 49, 3857 (2006) |
ALX-270-465 |
|
AS-252424 |
CAY-10009052 |
AS-604850
PI(3)K p110γ Isoform Selective Inhibitor.
Potent, cell permeable and ATP-competitive
inhibitor of phosphoinositide 3-kinase (PI(3)K) p110γ. Exhibits selectivity over other PI(3)K
isoforms. LIT: Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis:
M. Camps, et al.; Nat. Med. 11, 936 (2005) - Key role of the p110delta isoform of PI3K in B-cell antigen and IL-4 receptor
signaling: comparative analysis of genetic and pharmacologic interference with p110delta function in B cells: A. Bilancio,
et al.; Blood 107, 642 (2006) |
ALX-270-461 |
|
AS-604850 |
CAY-10010175 |
AS-605240
PI(3)K p110γ Isoform Selective Inhibitor.
Potent, cell permeable and ATP-competitive inhibitor of phosphoinositide 3-kinase (PI(3)K) p110γ. Exhibits selectivity over other PI(3)K
isoforms.
LIT: PI3Kgamma inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus: D.F. Barber, et
al.; Nat. Med. 11, 933 (2005) - Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid
arthritis: M. Camps, et al.; Nat. Med. 11, 936 (2005) |
ALX-270-462 |
|
AS-605240 |
CAY-10007707 |
|
Biotinylated-Crosstide |
BML-P191 |
|
BML-257 |
BML-EI336 |
|
CAY10567 |
CAY-10010233 |
|
Compound 15e |
ALX-270-455 |
|
Crosstide |
BML-P149 |
|
Deguelin |
BML-EI329 |
|
Deguelin |
ALX-350-118 |
|
DL-myo-Inositol 1,3,4,5-tetrakisphosphate . tetrapotassium salt |
ALX-307-032 |
|
DL-myo-Inositol 1,4,5,6-tetrakisphosphate . tetrapotassium salt |
ALX-307-033 |
|
DL-myo-Inositol 1,5-bisphosphate . dipotassium salt |
ALX-307-027 |
|
D-myo-Inositol 1,2,3,4,5-pentakisphosphate . decasodium salt |
ALX-307-074 |
|
D-myo-Inositol 1,2,3,4,6-pentakisphosphate . decasodium salt |
ALX-307-075 |
|
D-myo-Inositol 1,2,3,4-tetrakisphosphate . tetrapotassium salt |
ALX-307-040 |
|
D-myo-Inositol 1,2,3,5,6-pentakisphosphate . decasodium salt |
ALX-307-076 |
|
D-myo-Inositol 1,2,3,5-tetrakisphosphate . tetrapotassium salt |
ALX-307-031 |
|
D-myo-Inositol 1,2,3,6-tetrakisphosphate . tetrapotassium salt |
ALX-307-041 |
|
D-myo-Inositol 1,2,3-trisphosphate . tripotassium salt |
ALX-307-042 |
|
D-myo-Inositol 1,2,4,5-tetrakisphosphate . octasodium salt |
ALX-307-053 |
|
D-myo-Inositol 1,3,4,5,6-pentakisphosphate . pentapotassium salt |
ALX-307-037 |
|
D-myo-Inositol 1,3,4,5-tetrakisphosphate . tetrapotassium salt |
ALX-307-005 |
|
D-myo-Inositol 1,3,4-trisphosphate . hexapotassium salt |
ALX-307-006 |
|
D-myo-Inositol 1,3,5,6-tetrakisphosphate . tetrapotassium salt |
ALX-307-036 |
|
D-myo-Inositol 1,3,5-trisphosphate . hexasodium salt |
ALX-307-047 |
|
D-myo-Inositol 1,3,6-trisphosphate . hexasodium salt |
ALX-307-050 |
|
D-myo-Inositol 1,4,5,6-tetrakisphosphate . tetrapotassium salt |
ALX-307-034 |
|
D-myo-Inositol 1,4,5-trisphosphate (caged) . trisodium salt |
ALX-307-070 |
|
D-myo-Inositol 1,4,5-trisphosphate . hexapotassium salt |
ALX-307-007 |
|
D-myo-Inositol 1,4,5-trisphosphate . hexasodium salt |
ALX-307-009 |
|
D-myo-Inositol 1,4,5-trisphosphate . triammonium salt |
ALX-307-011 |
|
D-myo-Inositol 1,4,5-trisphosphate . trilithium salt |
ALX-307-013 |
|
D-myo-Inositol 1,4,6-trisphosphate . tripotassium salt |
ALX-307-029 |
|
D-myo-Inositol 1,5,6-trisphosphate . tripotassium salt |
ALX-307-043 |
|
D-myo-Inositol 1,5-bisphosphate . tetrapotassium salt |
ALX-307-028 |
|
D-myo-Inositol 1-monophosphate . dipotassium salt |
ALX-307-026 |
|
D-myo-Inositol 2,3,4,5,6-pentakisphosphate . decasodium salt |
ALX-307-077 |
|
D-myo-Inositol 2,3,5-trisphosphate . tripotassium salt |
ALX-307-030 |
|
D-myo-Inositol 3,4,5,6-tetrakisphosphate . octasodium salt |
ALX-307-061 |
|
D-myo-Inositol 3,4,5-trisphosphate . tripotassium salt |
ALX-307-044 |
|
D-myo-Inositol 3,4,5-trisphosphate, L-α-Phosphatidyl-(1,2-dipalmitoyl)- |
ALX-307-079 |
|
D-myo-Inositol 3,4,6-trisphosphate . hexasodium salt |
ALX-307-073 |
|
D-myo-Inositol 3,4-bisphosphate, L-α-Phosphatidyl-(1,2-dipalmitoyl)- |
ALX-307-038 |
|
D-myo-Inositol 3-monophosphate, L-α-Phosphatidyl-(1,2-dipalmitoyl)- |
ALX-307-080 |
|
D-myo-Inositol 4,5-bisphosphate, L-α-Phosphatidyl-(1,2-dipalmitoyl)- |
ALX-307-039 |
|
D-myo-Inositol 4-monophosphate, L-α-Phosphatidyl-(1,2-dipalmitoyl)- |
ALX-307-081 |
|
D-myo-Inositol 5-monophosphate, L-α-Phosphatidyl-(1,2-dipalmitoyl)- |
ALX-307-082 |
|
D-myo-Inositol-1,2,3,4-tetraphosphate . sodium salt |
CAY-10008448 |
|
D-myo-Inositol-1,2,3,5-tetraphosphate . sodium salt |
CAY-10008449 |
|
D-myo-Inositol-1,2,3,5-tetraphosphate . sodium salt |
CAY-10008451 |
|
D-myo-Inositol-1,2,3,6-tetraphosphate . sodium salt |
CAY-10008450 |
|
D-myo-Inositol-1,2,4,5,6-pentaphosphate . sodium salt |
CAY-10008452 |
|
D-myo-Inositol-1,2,5,6-tetraphosphate . sodium salt |
CAY-10008444 |
|
D-myo-Inositol-1,2,6-triphosphate . sodium salt |
CAY-10007780 |
|
D-myo-Inositol-1,2-diphosphate . sodium salt |
CAY-10008439 |
|
D-myo-Inositol-1,3,4,5,6-pentaphosphate . ammonium salt |
CAY-10009851 |
|
D-myo-Inositol-1,3,4,5,6-pentaphosphate . sodium salt |
CAY-10007784 |
|
D-myo-Inositol-1,3,4,6-tetraphosphate . ammonium salt |
CAY-10008442 |
|
D-myo-Inositol-1,3,4-triphosphate . sodium salt |
CAY-60972 |
|
D-myo-Inositol-1,3,5-triphosphate . sodium salt |
CAY-10007781 |
|
D-myo-Inositol-1,3-diphosphate . sodium salt |
CAY-10008443 |
|
D-myo-Inositol-1,4,5,6-Tetraphosphate . sodium salt |
CAY-10007783 |
|
D-myo-Inositol-1,4,5-triphosphate . hexapotassium salt |
BML-CA430 |
|
D-myo-Inositol-1,4,5-triphosphate . hexasodium salt |
BML-CA435 |
|
D-myo-Inositol-1,4,5-triphosphate . sodium salt |
CAY-10008205 |
|
D-myo-Inositol-1,4,5-triphosphate . trilithium salt |
BML-CA440 |
|
D-myo-Inositol-1,4,5-triphosphate . potassium salt |
CAY-60960 |
|
D-myo-Inositol-1,4,6-triphosphate . sodium salt |
CAY-10008427 |
|
D-myo-Inositol-1,4-diphosphate . sodium salt |
CAY-10008438 |
|
D-myo-Inositol-1,5-diphosphate . sodium salt |
CAY-10008441 |
|
D-myo-Inositol-1-phosphate . sodium salt |
CAY-10007777 |
|
D-myo-Inositol-2,3,4,5-tetraphosphate . ammonium salt |
CAY-10008456 |
|
D-myo-Inositol-2,3,5-triphosphate . ammonium salt |
CAY-10008423 |
|
D-myo-Inositol-2,4,5-triphosphate . sodium salt |
CAY-10007779 |
|
D-myo-Inositol-2,5,6-triphosphate . sodium salt |
CAY-10008424 |
|
D-myo-Inositol-3,4,5,6-tetraphosphate . sodium salt |
CAY-10007782 |
|
D-myo-Inositol-3,4,5-triphosphate . sodium salt |
CAY-10008425 |
|
D-myo-Inositol-3-phosphate . sodium salt |
CAY-10007778 |
|
D-myo-Inositol-4,5-diphosphate . sodium salt |
CAY-10008418 |
|
D-myo-Inositol-4-phosphate . ammonium salt |
CAY-10008437 |
|
Epigallocatechin Gallate |
CAY-70935 |
|
Epigallocatechin gallate |
LKT-E6234 |
|
Fumonisin B1 |
ALX-350-017 |
|
Gambogic amide |
BML-N159 |
|
H-89 |
CAY-10010556 |
|
H-89 . 2HCl |
BML-EI196 |
|
H-89 . dihydrochloride |
ALX-270-017 |
|
Inositol |
LKT-I5357 |
|
iso-Ins(1,4,5)P3/PM (caged) |
ALX-307-071 |
|
L-Quebrachitol |
ALX-307-001 |
|
Luteolin |
ALX-385-007 |
|
Luteolin |
CAY-10004161 |
|
Luteolin |
LKT-L8377 |
|
LY 294002 |
BML-ST420 |
LY-294,002 Bulk!
Potent, cell permeable inhibitor of phosphoinositide 3-kinase (PI(3)K) that acts on the
ATP binding site of the enzyme. |
ALX-270-038 |
|
LY294002 |
CAY-70920 |
|
LY294002 |
JBS-INH-002 |
LY-303,511 Bulk!
Useful negative control for the PI(3)K inhibitor LY-294,002 (Prod. No. ALX-270-038).
Does not inhibit phosphoinositide 3-kinase (PI(3)K) even at concentrations ≥100μM
(LY-294,002: IC50=1.4μM). |
ALX-270-410 |
|
L-α-Phosphatidylinositol |
BML-PH100 |
|
L-α-Phosphatidylinositol-3,4,5-P3 |
BML-PH107 |
|
L-α-Phosphatidylinositol-3,4-P2 |
BML-PH106 |
|
L-α-Phosphatidylinositol-3-P |
BML-PH105 |
|
L-α-Phosphatidylinositol-4-P |
BML-PH101 |
|
ML-9 |
BML-EI153 |
|
ML-9 |
CAY-10010236 |
|
myo-Inositol |
ALX-307-003 |
|
Myo-inositol galactoside |
MGT-M0326 |
|
N-Acetyl-Asp-Tyr(2-malonyl)-Val-Pro-Met-Leu-NH2 |
ALX-151-026 |
|
N-Acetyl-Asp-Tyr(PO3H2)-Val-Pro-Met-Leu-NH2 |
ALX-151-027 |
|
NaD-myo-Inositol-1,3,4,5-tetraphosphate . sodium salt |
CAY-60980 |
|
N-Arachidonoyl-L-serine |
ALX-340-063 |
|
N-Arachidonoyl-L-serine |
CAY-10005455 |
|
Naringenin |
LKT-N0068 |
|
PAK4/AKT Peptide Substrate |
BML-P194 |
|
Paxilline |
ALX-630-019 |
|
Paxilline |
LKT-P0392 |
|
PI |
JBS-LI-001 |
|
PI |
JBS-LI-008 |
PI-103
PI(3)K Inhibitor with an Interesting Profile. Potent, cell permeable and ATP-competitive inhibitor
of DNA-PK, phosphoinositide 3-kinase (PI(3)K), the rapamycin-sensitive (mTORC1) and
rapamycin-insensitive (mTORC2) complexes of the protein kinase mTOR. Exhibits little activity
towards a panel of more than 40 other kinases even at concentrations as high as 10μM. Effectively
blocks cell proliferation in glioma cell lines both in vitro and in vivo.
LIT: A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma: Q.W. Fan, et
al.; Cancer Cell 9, 341 (2006) - A pharmacological map of the PI3-K famisly defines a role for
p110alpha in insulin signaling: Z.A. Knight, et al.; Cell 125, 733 (2006) |
ALX-270-460 |
|
PI-103 |
CAY-10009209 |
|
PI3-Kinase α Inhibitor 2 |
CAY-10010177 |
|
PI-4,5-P2 |
JBS-LI-003 |
|
PI-4,5-P2 |
JBS-LI-010 |
|
PI-4-P |
JBS-LI-002 |
|
PI-4-P |
JBS-LI-009 |
|
PKC412 |
ALX-380-281 |
|
PLC Thio-PIP2 . sodium salt |
CAY-10007839 |
|
PRAS40 (pThr246) Control Peptide Pair |
BML-SP360 |
|
Ptd(S)Ins-(3,4)-P2 (1,2-dioctanoyl) . sodium salt |
CAY-10010181 |
|
Ptd(S)Ins-(3,4)-P2 (1,2-dipalmitoyl) . sodium salt |
CAY-10010112 |
|
PtdIns-(1,2-dioctanoyl) . sodium salt |
CAY-10008099 |
|
PtdIns-(1,2-dipalmitoyl) . ammonium salt |
CAY-10007710 |
|
PtdIns-(3)-P1 (1,2-dioctanoyl) . sodium salt |
CAY-10008394 |
|
PtdIns-(3)-P1 (1,2-dipalmitoyl) (triammonium salt) |
CAY-64921 |
|
PtdIns-(3)-P1 (1,2-dipalmitoyl)-d62 . ammonium salt |
CAY-10005616 |
|
PtdIns-(3,4)-P2 (1,2-dihexanoyl) . sodium salt |
CAY-10007759 |
|
PtdIns-(3,4)-P2 (1,2-dioctanoyl) . sodium salt |
CAY-10008400 |
|
PtdIns-(3,4)-P2 (1,2-dipalmitoyl) |
CAY-64922 |
|
PtdIns-(3,4,5)-P3 (1,2-dioctanoyl) . sodium salt |
CAY-10007764 |
|
PtdIns-(3,4,5)-P3 (1,2-dipalmitoyl) |
CAY-64920 |
|
PtdIns-(3,4,5)-P3 (1-stearoyl, 2-arachidonyl) |
CAY-64930 |
|
PtdIns-(3,4,5)-P3-biotinamide . sodium salt |
CAY-10009531 |
|
PtdIns-(3,4,5)-P3-fluorescein . triethylammonium salt |
CAY-10010383 |
|
PtdIns-(3,5)-P2 (1,2-dihexanoyl) . sodium salt |
CAY-10008396 |
|
PtdIns-(3,5)-P2 (1,2-dioctanoyl) . sodium salt |
CAY-10007763 |
|
PtdIns-(3,5)-P2 (1,2-dipalmitoyl) . trisodium salt |
CAY-10008398 |
|
PtdIns-(4)-P1 (1,2-dihexanoyl) . sodium salt |
CAY-10007757 |
|
PtdIns-(4)-P1 (1,2-dioctanoyl) . ammonium salt |
CAY-10007711 |
|
PtdIns-(4)-P1 (1,2-dipalmitoyl) |
CAY-64923 |
|
PtdIns-(4,5)-P2 (1,2-dihexanoyl) . sodium salt |
CAY-10007762 |
|
PtdIns-(4,5)-P2 (1,2-dioctanoyl) |
CAY-64910 |
|
PtdIns-(4,5)-P2 (1,2-dipalmitoyl) |
CAY-64924 |
|
PtdIns-(4,5)-P2 (1,2-dipalmitoyl) . sodium salt |
CAY-10008115 |
|
PtdIns-(4,5)-P2 (1,2-dipalmitoyl)-d62 . sodium salt |
CAY-10005615 |
|
PtdIns-(4,5)-P2-biotinamide . sodium salt |
CAY-10008159 |
|
PtdIns-(4,5)-P2-fluorescein . triethylammonium salt |
CAY-10010388 |
|
PtdIns-(5)-P1 (1,2-dihexanoyl) . sodium salt |
CAY-10008050 |
|
PtdIns-(5)-P1 (1,2-dioctanoyl) . ammonium salt |
CAY-10007758 |
|
PtdIns-(5)-P1 (1,2-dipalmitoyl) |
CAY-64925 |
|
Rapamycin |
ALX-380-004 |
|
Rapamycin |
BML-A275 |
|
Rapamycin |
BV-1568 |
|
Rapamycin |
LKT-R0161 |
|
S6 Peptide |
BML-P116 |
|
S6 Ribosomal Protein/Peptide |
BML-P144 |
|
S6-1 |
LKT-S0006 |
|
scyllo-Inositol ; Scyllitol |
ALX-307-004 |
|
SH-5 |
ALX-270-349 |
|
SH-6 |
ALX-270-350 |
|
TG 100-115 |
CAY-10010512 |
|
TGX-221 |
ALX-270-464 |
TGX-221
PI(3)K p110β Isoform
Selective Inhibitor. Potent, selective and cell permeable inhibitor of phosphoinositide 3-kinase (PI(3)K) p110β.
LIT: Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human
but not murine neutrophils: A.M. Condliffe, et al.; Blood 106, 1432 (2005)
- PI 3-kinase p110beta: a new target for antithrombotic therapy: S.P. Jackson, et al.; Nat.
Med. 11, 507 (2005) |
CAY-10007349 |
|
Triciribine |
BML-EI332 |
|
Triciribine |
CAY-10010237 |
|
Wortmannin |
ALX-350-020 |
|
Wortmannin |
BML-ST415 |
|
Wortmannin |
CAY-10010591 |
|
Wortmannin |
LKT-W5769 |
|
Xestospongin C |
ALX-350-382 |
|
Xestospongin C |
BML-CA409 |
|
Xestospongin C |
CAY-64950 |
ZSTK474
PI(3)K Inhibitor with Antitumor Activity. Cell permeable, reversible, potent and specific
inhibitor of phosphoinositide 3-kinase (IC50=17nM for PI(3)K p110β, IC50=53nM for
PI(3)K p110γ and IC50=6nM for PI(3)K p110δ). Blocks cellular PI(3)K/Akt signalling in vitro and
inhibits Akt-dependent tumor growth in mice in vivo without significant toxic effect. More
effective than LY-294,002 (Prod. No. ALX-270-038) in vitro and in vivo. LIT: A novel phosphatidylinositol 3-kinase inhibitor, ZSTK474
exerted antitumor activity against human tumor xenografts by oral administration: S.Yaguchi et al.; Proc. Am. Assoc. Cancer
Res. 46, 1691 (2005) - Antitumor activity of ZSTK474, a new phosphatidylinositol 3-kinase inhibitor: S. Yaguchi, et al.;
J. Natl. Cancer Inst. 98, 545 (2006)
Not sold in USA & Japan |
ALX-270-454 |
